Can mortality data be used to estimate amyotrophic lateral sclerosis incidence?

Neuroepidemiology

Volumn 36, Issue 1, 2011, Pages 29-38

  Marin, Benoît ^a,b   Couratier, Philippe ^a,b   Preux, Pierre Marie ^a,b   Logroscino, Giancarlo ^c  

^a UNIVERSITÉ DE LIMOGES   (France)

^b LIMOGES UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

Amyotrophic lateral sclerosis; Death certificate; Incidence; Mortality; Motor neuron disease

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; DEATH CERTIFICATE; ETHNICITY; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HUMAN; INCIDENCE; MORTALITY; REVIEW; SYSTEMATIC REVIEW;

AMYOTROPHIC LATERAL SCLEROSIS; DEATH CERTIFICATES; HUMANS; INCIDENCE; UNITED STATES;

EID: 78349233579     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321930     Document Type: Review

References (70)

1. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O: Incidence and prevalence of ALS in Ireland, 1995-1997: a populationbased study. Neurology 1999; 52: 504-509.
2. The Scottish Motor Neuron Disease Register: a prospective study of adult onset motor neuron disease in Scotland - methodology, demography and clinical features of incident cases in 1989. J Neurol Neurosurg Psychiatry 1992; 55: 536-541.
3. Yoshida S, Mulder DW, Kurland LT, Chu CP, Okazaki H: Follow-up study on amyotrophic lateral sclerosis in Rochester, Minn., 1925 through 1984. Neuroepidemiology 1986; 5: 61-70.
4. Logroscino G, Beghi E, Zoccolella S, Palagano R, Fraddosio A, Simone IL, Lamberti P, Lepore V, Serlenga L: Incidence of amyotrophic lateral sclerosis in southern Italy: a population-based study. J Neurol Neurosurg Psychiatry 2005; 76: 1094-1098. (Pubitemid 41081283)
5. Beghi E, Millul A, Micheli A, Vitelli E, Logroscino G: Incidence of ALS in Lombardy, Italy. Neurology 2007; 68: 141-145.
6. Marin B, Gil J, Preux PM, Funalot B, Couratier P: Incidence of amyotrophic lateral sclerosis in the Limousin region of France, 1997-2007. Amyotroph Lateral Scler 2009; 10: 216-220.
7. Piemonte and Valle d'Aosta Register for Amyotrophic Lateral Sclerosis (PARALS):Incidence of ALS in Italy: evidence for a uniform frequency in Western countries. Neurology 2001; 56: 239-244.
8. Logroscino G, Traynor BJ, Hardiman O, Chio A, Couratier P, Mitchell JD, Swingler RJ, Beghi E: Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry 2008; 79: 6-11.
9. Durrleman S, Alperovitch A: Increasing trend of ALS in France and elsewhere: are the changes real? Neurology 1989; 39: 768-773.
10. Chio A, Magnani C, Schiffer D: Gompertzian analysis of amyotrophic lateral sclerosis mortality in Italy, 1957-1987: application to birth cohorts. Neuroepidemiology 1995; 14: 269-277.
11. Riggs JE: Longitudinal gompertzian analysis of amyotrophic lateral sclerosis mortality in the US, 1977-1986: evidence for an inherently susceptible population subset. Mech Ageing Dev 1990; 55: 207-220.
12. Neilson S, Robinson I, Alperovitch A: Rising amyotrophic lateral sclerosis mortality in France 1968-1990: increased life expectancy and inter-disease competition as an explanation. J Neurol 1994; 241: 448-455.
13. Neilson S, Gunnarsson LG, Robinson I: Rising mortality from motor neurone disease in Sweden 1961-1990: the relative role of increased population life expectancy and environmental factors. Acta Neurol Scand 1994; 90: 150-159.
14. Neilson S, Robinson I, Hunter M: Static and dynamic models of interdisease competition: past and projected mortality from amyotrophic lateral sclerosis and multiple sclerosis. Mech Ageing Dev 1993; 66: 223-241.
15. Neilson S, Robinson I, Hunter M: Longitudinal gompertzian analysis of ALS mortality in England and Wales, 1963-1989: estimates of susceptibility in the general population. Mech Ageing Dev 1992; 64: 201-216.
16. Neilson S, Robinson I, Rose FC: Mortality from motor neuron disease in Japan, 1950-1990: association with radioactive fallout from atmospheric weapons testing. J Neurol Sci 1995; 134: 61-66.
17. Neilson S, Robinson I, Nymoen EH: Longitudinal analysis of amyotrophic lateral sclerosis mortality in Norway, 1966-1989: evidence for a susceptible subpopulation. J Neurol Sci 1994; 122: 148-154.
18. Jougla E, Pavillon G, Rossollin F, de Smedt M, Bonte J: Improvement of the quality and comparability of causes-of-death statisticsinside the European Community. EUROSTAT Task Force on 'causes of death statistics'. Rev Epidemiol Sante Publique 1998; 46: 447-456.
19. Belsh JM, Schiffman PL: Misdiagnosis in patients with amyotrophic lateral sclerosis. Arch Intern Med 1990; 150: 2301-2305.
20. Chio A: ISIS Survey: an international study on the diagnostic process and its implications in amyotrophic lateral sclerosis. J Neurol 1999; 246(suppl 3):III1-III5.
21. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O: Amyotrophic lateral sclerosis mimic syndromes: a population-based study. Arch Neurol 2000; 57: 109-113.
22. Davenport RJ, Swingler RJ, Chancellor AM, Warlow CP: Avoiding false-positive diagnoses of motor neuron disease: lessons from the Scottish Motor Neuron Disease Register. J Neurol Neurosurg Psychiatry 1996; 60: 147-151.
23. Lilienfeld DE, Chan E, Ehland J, Godbold J, Landrigan PJ, Marsh G, Perl DP: Rising mortality from motoneuron disease in the USA, 1962-84. Lancet 1989;i:710-713.
24. Brooks BR, Miller RG, Swash M, Munsat TL: El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 293-299.
25. Okamoto K, Kobashi G, Washio M, Sasaki S, Yokoyama T, Miyake Y, Sakamoto N, Tanaka H, Inaba Y: Descriptive epidemiology of amyotrophic lateral sclerosis in Japan, 1995-2001. J Epidemiol 2005; 15: 20-23.
26. Bensimon G, Lacomblez L, Meininger V: A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med 1994; 330: 585-591.
27. Forbes RB, Colville S, Cran GW, Swingler RJ: Unexpected decline in survival from amyotrophic lateral sclerosis/motor neurone disease. J Neurol Neurosurg Psychiatry 2004; 75: 1753-1755.
28. Qureshi M, Schoenfeld DA, Paliwal Y, Shui A, Cudkowicz ME: The natural history of ALS is changing: improved survival. Amyotroph Lateral Scler 2009; 10: 324-331.
29. Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Samarelli V, Lepore V, Simone IL, Lamberti P, Serlenga L, Logroscino G: Predictors of long survival in amyotrophic lateral sclerosis: a population-based study. J Neurol Sci 2008; 268: 28-32.
30. Gil J, Funalot B, Verschueren A, Danel-Brunaud V, Camu W, Vandenberghe N, Desnuelle C, Guy N, Camdessanche JP, Cintas P, Carluer L, Pittion S, Nicolas G, Corcia P, Fleury MC, Maugras C, Besson G, le Masson G, Couratier P: Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study. Eur J Neurol 2008; 15: 1245-1251.
31. Corcia P, Pradat PF, Salachas F, Bruneteau G, Forestier N, Seilhean D, Hauw JJ, Meininger V: Causes of death in a post-mortem series of ALS patients. Amyotroph Lateral Scler 2008; 9: 59-62.
32. Kurian KM, Forbes RB, Colville S, Swingler RJ: Cause of death and clinical grading criteria in a cohort of amyotrophic lateral sclerosis cases undergoing autopsy from the Scottish Motor Neurone Disease Register. J Neurol Neurosurg Psychiatry 2009; 80: 84-87.
33. Johansen C, Olsen JH: Mortality from amyotrophic lateral sclerosis, other chronic disorders, and electric shocks among utility workers. Am J Epidemiol 1998; 148: 362-368.
34. Kondo K, Tsubaki T: Changing mortality patterns of motor neuron disease in Japan. J Neurol Sci 1977; 32: 411-424.
35. Jokelainen M: The epidemiology of amyotrophic lateral sclerosis in Finland: a study based on the death certificates of 421 patients. J Neurol Sci 1976; 29: 55-63.
36. Chio A, Magnani C, Schiffer D: Amyotrophic lateral sclerosis mortality in Italy, 1958 to 1987: a cross-sectional and cohort study. Neurology 1993; 43: 927-930.
37. Brooks BR: El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial 'Clinical limits of amyotrophic lateral sclerosis' workshop contributors. J Neurol Sci 1994; 124 (suppl):96-107.
38. Seljeseth YM, Vollset SE, Tysnes OB: Increasing mortality from amyotrophic lateral sclerosis in Norway? Neurology 2000; 55: 1262-1266.
39. Chancellor AM, Swingler RJ, Fraser H, Clarke JA, Warlow CP: Utility of Scottish morbidity and mortality data for epidemiological studies of motor neuron disease. J Epidemiol Community Health 1993; 47: 116-120.
40. Dean G: Motor neuron disease in a defined English population: estimates of incidence and mortality. J Neurol Neurosurg Psychiatry 1994; 57: 450-454.
41. Kurtzke JF, Beebe GW: Epidemiology of amyotrophic lateral sclerosis. 1. A case-control comparison based on ALS deaths. Neurology 1980; 30: 453-462.
42. Buckley J, Warlow C, Smith P, Hilton-Jones D, Irvine S, Tew JR: Motor neuron disease in England and Wales, 1959-1979. J Neurol Neurosurg Psychiatry 1983; 46: 197-205.
43. O'Malley F, Dean G, Elian M: Multiple sclerosis and motor neurone disease: survival and how certified after death. J Epidemiol Community Health 1987; 41: 14-17.
44. Chio A, Magnani C, Oddenino E, Tolardo G, Schiffer D: Accuracy of death certificate diagnosis of amyotrophic lateral sclerosis.J Epidemiol Community Health 1992; 46: 517-518.
45. Ragonese P, Filippini G, Salemi G, Beghi E, Citterio A, D'Alessandro R, Marini C, Monsurrò MR, Aiello I, Morgante L, Tempestini A, Fratti C, Ragno M, Pugliatti M, Epifanio A, Testa D, Savettieri G: Accuracy of death certificates for amyotrophic lateral sclerosis varies significantly from north to south of Italy: implications for mortality studies. Neuroepidemiology 2004; 23: 73-77.
46. Hoffman PM, Brody JA: The reliability of death certificate reporting for amyotrophic lateral sclerosis. J Chronic Dis 1971; 24: 5-8.
47. Ragonese P, Salemi G, Aridon P, Conte S, Cuccia G, Lupo I, Savettieri G: Accuracy of death certificates for motor neuron disease and multiple sclerosis in the province of Palermo in southern Italy. Neuroepidemiology 2002; 21: 148-152.
48. Noonan CW, White MC, Thurman D, Wong LY: Temporal and geographic variation in United States motor neuron disease mortality, 1969-1998. Neurology 2005; 64: 1215-1221.
49. Leone M, Chandra V, Schoenberg BS: Motor neuron disease in the United States, 1971 and 1973-1978: patterns of mortality and associated conditions at the time of death. Neurology 1987; 37: 1339-1343.
50. Forbes RB, Colville S, Swingler RJ: The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 or over. Age Ageing 2004; 33: 131-134.
51. Gunnarsson LG, Lindberg G, Söderfelt B, Axelson O: The mortality of motor neuron disease in Sweden. Arch Neurol 1990; 47: 42-46.
52. Riggs JE, Schochet SS Jr: Rising mortality due to Parkinson's disease and amyotrophic lateral sclerosis: a manifestation of the competitive nature of human mortality. J Clin Epidemiol 1992; 45: 1007-1012.
53. Roman GC: Neuroepidemiology of amyotrophic lateral sclerosis: clues to aetiology and pathogenesis. J Neurol Neurosurg Psychiatry1996; 61: 131-137.
54. Veiga-Cabo J, Almazán-Isla J, Sendra- Gutiérrez JM, de Pedro-Cuesta J: Differential features of motor neuron disease mortality in Spain. Int J Epidemiol 1997; 26: 1024-1032.
55. Fong KY, Yu YL, Chan YW, Kay R, Chan J, Yang Z, Kwan MC, Leung KP, Li PC, Lam TH, Cheung RT: Motor neuron disease in Hong Kong Chinese: epidemiology and clinical picture. Neuroepidemiology 1996; 15: 239-245.
56. Jokelainen M: Amyotrophic lateral sclerosis in Finland. 1. An epidemiologic study. Acta Neurol Scand 1977; 56: 185-193. (Pubitemid 8185863)
57. Hudson AJ, Davenport A, Hader WJ: The incidence of amyotrophic lateral sclerosis in southwestern Ontario, Canada. Neurology 1986; 36: 1524-1528.
58. Elian M, Dean G: The changing mortality from motor neurone disease and multiple sclerosis in England and Wales and the Republic of Ireland. Neuroepidemiology 1992; 11: 236-243.
59. Maasilta P, Jokelainen M, Löytönen M, Sabel CE, Gatrell AC: Mortality from amyotrophic lateral sclerosis in Finland, 1986-1995. Acta Neurol Scand 2001; 104: 232-235.
60. Neilson S, Robinson I, de Pedro-Cuesta J, Veiga-Cabo J: Decline and rise of mortality from motor neuron disease in Spain, 1960-1989: demographic, environmental and competitive influences. Neuroepidemiology 1996; 15: 180-191.
61. Stallones L, Kasarskis EJ, Stipanowich C,Snider G: Secular trends in mortality rates from motor neuron disease in Kentucky 1964-1984. Neuroepidemiology 1989; 8: 68-78.
62. Torny F, Lacoste M, Nguyen JM, Tymoczko- Nguyen ME, Couratier P: Analysis of reasons for the late diagnosis of amyotrophic lateral sclerosis (in French). Rev Neurol (Paris) 2006; 162: 617-622.
63. Chio A: Mortality trends in ALS: an increasingly intricate puzzle. Lancet Neurol 2005; 4: 453-454.
64. Cronin S, Hardiman O, Traynor BJ: Ethnic variation in the incidence of ALS: a systematic review. Neurology 2007; 68: 1002-1007.
65. Mandrioli J, Faglioni P, Merelli E, Sola P: The epidemiology of ALS in Modena, Italy. Neurology 2003; 60: 683-689.
66. Dean G, Elian M: Motor neuron disease and multiple sclerosis mortality in Australia, New Zealand and South Africa compared with England and Wales. J Neurol Neurosurg Psychiatry 1993; 56: 633-637.
67. Bharucha NE, Schoenberg BS, Raven RH, Pickle LW, Byar DP, Mason TJ: Geographic distribution of motor neuron disease and correlation with possible etiologic factors. Neurology 1983; 33: 911-915.
68. Matsumoto N, Worth RM, Kurland LT, Okazaki H: Epidemiologic study of amyotrophic lateral sclerosis in Hawaii: identification of high incidence among Filipino men. Neurology 1972; 22: 934-940.
69. Sejvar JJ, Holman RC, Bresee JS, Kochanek KD, Schonberger LB: Amyotrophic lateral sclerosis mortality in the United States, 1979-2001. Neuroepidemiology 2005; 25: 144-152.
70. Zaldivar T, Gutiérrez J, Lara G, Carbonara M, Logroscino G, Hardiman O: Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study. Neurology 2009; 72: 1640-1645.